市況評論

作者

倪國權先生 (Alex Ni)
助理經理

曾任職鋼材交易員及廣告公司主任,所以特別喜歡研究資源類及消費類股票。歡迎來電賜教或交流心得。
電話:
22776779

現代牙科 Modern Dental Group Limited (3600)

2025年12月18日 星期四 觀看次數518

現代牙科

Stock:

Modern Dental Group Ltd

 

1 Month H/L:

4.92 – 5.60

Stock Code:

3600.HK

 

52 week H/L:

3.281 – 5.810

Market Cap.:

HKD 4.702 B

 

Listing date:

15/12/2015

Stock Outstanding:

810,955,244 shares

 

Listing price:

4.20

P/E (TTM):

11.644x

 

Chairman & CEO:

Dr. Sun Yiu Kwong

Dividend:

0.107 (interim)

 

Major Shareholdes:

1. Chan Kwun Fung& Family – 50.74%

2. Ngai Shing Kin -                    10.49%

3. Ngai Chi Ho Alwin  –              6.75%

Dividend Yield(annualised):

3.933%

 

 

 

 

Modern Dental Group Ltd has demonstrated robust recent financial performance, with strong growth in key markets and an aggressive move into digital dental solutions. The group's strategy and diversified presence support its positive financial outlook despite global challenges​

Recent Financial Performance

For the first half of 2025, Modern Dental Group Ltd reported revenue of approximately HK$1,834.8 million, a year-on-year increase of about 7.8% compared to the previous period. The company recorded a gross profit of HK$1,005.5 million (gross margin 54.8%), up 10% year-on-year, and EBITDA surged 21.6% to about HK$456.7 million. Notably, net profit for the period reached HK$288.7 million, representing a 34.7% increase over the prior year, and the company achieved record-high profitability despite industry headwinds and general softness in certain regional markets.​

Business Segment Review

Modern Dental Group Ltd operates three main business segments:

  • Fixed Prosthetic Devices: Includes crowns, bridges, and implants. This is the largest segment, contributing significantly to total revenue (recent years: HK$1.99B–HK$2.05B annually).​
  • Removable Prosthetic Devices: Includes full and partial dentures, with segment revenues rising steadily (HK$713M–HK$799M annually)​
  • Other Devices: Covers orthodontic appliances, sports guards, clear aligners, and education services. This segment is also benefiting from increased adoption of digital workflow products, especially digital dentures and intra-oral scanners, which grew more than 60% year-on-year in use in 2024.​

Geographically, Europe and Australia remain the strongest growth drivers, with Europe accounting for about 48% of group revenue and showing strong double-digit revenue gains. The acquisition of Hexa Ceram in Thailand in early 2025 has also strengthened its production platform in Asia.​

Recent Financial Position

As of the latest full year, Modern Dental Group Ltd maintained a solid balance sheet:

  • Total Assets: Approximately HK$4,075 million by the end of 2024, up year-on-year.​
  • Total Equity: Around HK$2,726 million, reflecting prudent management and reinvestment into operations.​
  • Cash Flow: The group generated strong cash from operations (over HK$500 million in 2024) and healthy levered free cash flow, indicative of robust underlying profitability.​
  • Liabilities: The company managed its current liabilities conservatively, maintaining a comfortable liquidity position.​

Future Prospects

Modern Dental Group Ltd is optimistic about mid- to long-term growth. Industry consolidation and accelerated digitalization of dental services are likely to support future expansion, with further upside from cross-border integration, product innovation, and deepening digital penetration.

Key growth catalysts include:

  • Further expansion in Europe, Australia, and Southeast Asia
  • Increased adoption of digital dental technologies
  • Market share gains as consolidation continues and regulatory measures favor larger, well-established providers​
  • Potential for incrementally higher dividends as margins improve and cash flow remains strong​

In summary, Modern Dental Group Ltd is well positioned to defend and expand its leadership in global dental prosthetics through its focus on digital transformation, strategic acquisitions, and geographical diversification, despite ongoing global economic uncertainties.

 

 

「註:本人倪國權為證監會持牌人士。截至本評論文章發表日止,本人及/或其有聯繫者並無持有全部提及之証券的所有相關財務權益。」; Or
” I, Ni Kwok Kuen Alex, am a licensed person under the Securities and Futures Commission. Until the date this commentary was published, neither I and/or my affiliates are the beneficiary of the securities mentioned herein or are entitled to any financial interests in relation thereto. “

研究報告由輝立証券集團旗下於香港證監會持牌的輝立証券(香港)有限公司及/ 或輝立商品有限公司(“輝立”)所發報。本文所包含的資料均為輝立從相信為準確的來源搜集。輝立對有關報告所引致之任何損失或虧損概不負責。本報告所載的資料只供参考用途,並沒有法律約束力,亦不構成投資建議、邀約、購入、出售任何產品。
投資涉及風險,有可能損失投資本金。你應諮詢專業人士,就本身的投資經驗、財務狀況、個人目標及風險取向,以提供投資意見。各類產品的風險,請參閱本公司網頁 http://www.phillip.com.hk《風險披露聲明》。
輝立(或其僱員) 可能持有本文所述有關的投資產品。此外,輝立(或任何附屬公司)隨時可能替向報告內容所述及的公司提供服務、招攬或業務往來。
以上資料為輝立擁有並受版權及知識產權法保護。除非事先得到輝立明確書面批准,否則不應複製、散播或發佈。
返回頁首
聯絡我們
請即聯絡你的客戶主任或致電我們。
研究部
電話 : (852) 2277 6846
傳真 : (852) 2277 6565
電郵 : businessenquiry@phillip.com.hk

查詢及支援
分行資料
投訴程序
關於輝立
輝立簡介
招聘人才
集團網絡
輝立通訊
輝立頻道
輝立保險/股票/期貨100%回佣計劃
新聞稿
查數網
登入
研究部快訊
免費訂閱
聯絡我們